Global Anti Diarrheal Drugs Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. The Antidiarrheal drug is any drug that relieves signs of diarrhea and can be differentiated into groups based on chemical or functional similarities. The WHO stated that diarrhea is second leading cause of death, especially in children of age group less than 5 years. In addition, it is known to be the main cause of malnutrition in children. The treatments such as nutrient rich food, rehydration therapies, and administration of zinc supplements help to treat the diarrheal disease.
The factors that are playing a major role in the growth of Anti Diarrheal Drugs Market are, increasing government initiative to develop healthcare infrastructure and provide best healthcare facilities, rising awareness for antidiarrheal drugs, and rising occurrence for diarrhea cases. On the other hand, factors that are restraining overall market growth are drugs side effects like bloating, constipation, nausea or vomiting, dizziness, and fullness.
Anti Diarrheal Drugs Industry is segmented based on types, product types, applications, and region. Types such as OTC Drugs, Prescription Drugs, and others classify Anti Diarrheal Drugs Market. Product types such as Mucosal Protectants and Absorbents (Kaolin-Pectin and Activated Charcoal), and Motility Modifying Drugs (Anticholinergics & Opiates, Antimicrobial Therapy, Anti-Toxins, and Non-Steroidal Anti-Kaopectate) classify Anti Diarrheal Drugs Industry. Applications into Adults, Children, and others classify Anti Diarrheal Drugs Market. Anti Diarrheal Drugs Industry is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.
Globally, North America accounts the largest market share of Anti Diarrheal Drugs Industry and is estimated to lead the overall market in the upcoming years. This is mainly due to the high demand for antidiarrheal drugs and high occurrence of diarrhea cases. The United States is the key consumer of Anti Diarrheal Drugs Market. Europe and Asia Pacific follow suit.
On the other hand, Asia Pacific is estimated to grow at fastest pace in the upcoming years. The emerging economies like India and China are the major consumer of Anti Diarrheal Drugs Market in Asia Pacific. The reason being, unhygienic and improper sanitation procedures, raising awareness in the healthcare facilities and infrastructure.
The key players of Anti Diarrheal Drugs Industry are Pfizer, Actelion, Perrigo, Lupin, Glenmark Pharmaceuticals, and GSK. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
This report studies the global Anti Diarrheal Drugs market, analyzes and researches the Anti Diarrheal Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• Glenmark Pharmaceuticals
Market segment by Regions/Countries, this report covers
• United States
• Southeast Asia
Market segment by Type, the product can be split into
• Prescription Drugs
• OTC Drugs
Market segment by Application, Anti Diarrheal Drugs can be split into
Research Support Specialist, USA